iScreen® OFD Cotinine Drugs of Abuse Test
803698BX

$0.00

  • The Alere iScreen OFD is a rapid, screening test for the simultaneous detection of cotinine; it is a lateral flow chromatographic immunoassay for the qualitative detection in oral fluids at a cut-off concentrations of 30 ng/mL
  • Results in 10 minutes
  • Box contains 25 test devices, caps, sponge protectors, procedure cards, security seals and package insert

37 in stock

Description

The Alere iScreen OFD Cotinine Test Device is a rapid, oral fluid screening test that can be performed without the use of an instrument. The test utilizes antibodies to selectively detect elevated levels of specific drugs in human oral fluid. Cotinine is the first-stage metabolite of nicotine, a toxic alkaloid that stimulates the autonomic ganglia and central nervous system in humans. Nicotine is a drug to which virtually every member of a tobacco-smoking society is exposed whether through direct contact or second-hand inhalation. Aside from tobacco, nicotine is also commercially available as the active ingredient in smoking replacement therapies such as nicotine gum, transdermal patches and nasal sprays. Cotinine demonstrates a substantially longer half-life than nicotine, bears a high correlation with plasma cotinine levels and has been found to be the best marker for smoking status. The window of detection for cotinine in saliva at a cutoff level of 30 ng/mL is expected to be up to 4 days after nicotine use.